Stocksigma LogoStocksigma Logo

Vanta Bioscience Reports H1 FY27 Results with Turnaround to Consolidated Net Profit

Vanta Bioscience reported consolidated revenue from operations of Rs. 105.74 lakhs for the half year ended 30th Sep'26, up 250.36% YoY from Rs

Vanta Bioscience Reports H1 FY27 Results with Turnaround to Consolidated Net Profit

Vanta Bioscience Ltd 路 Financial Result 路 14 Nov 2026, 12:31 am

Vanta Bioscience Reports H1 FY27 Results with Turnaround to Consolidated Net Profit Vanta Bioscience reported consolidated revenue from operations of Rs. 105.74 lakhs for the half year ended 30th Sep'26, up 250.36% YoY from Rs. 30.18 lakhs in the prior-year period. Total consolidated income stood at Rs. 109.95 lakhs. The group achieved a turnaround with a consolidated net profit after tax of Rs. 5.14 lakhs, compared to a net loss of Rs. 181.89 lakhs in H1 FY26. Consolidated basic and diluted EPS came in at Rs. 0.07 versus negative Rs. 2.56 YoY.

Original exchange filing (PDF)

More announcements from Vanta Bioscience Ltd

All Vanta Bioscience Ltd announcements